Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.33 |
| ▸ | EHMT2 | Q96KQ7 | 2/20 | 0.33 |
| ▸ | EHMT1 | Q9H9B1 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14523884 | 0.84 | TDP1 (0.35) | CA1CA2CA7CA9BBOX1 | |
| SCHEMBL339826 | 0.79 | BBOX1 (0.41) | CA1CA2CA7CA9BBOX1 | |
| Bromide SCHEMBL9081012 | 0.76 | BBOX1 (0.39) | CA1CA2CA7CA9BBOX1 | |
| Hydrochloric Acid SCHEMBL30702244 | 0.76 | BBOX1 (0.39) | CA1CA2CA7CA9BBOX1 | |
| SCHEMBL26417080 | 0.76 | BBOX1 (0.39) | CA1CA2CA7CA9BBOX1 | |
| Benzene SCHEMBL27586265 | 0.76 | BBOX1 (0.39) | CA1CA2CA7CA9BBOX1 | |
| SCHEMBL24553843 | 0.73 | CA2 (0.43) | CA1CA2CA7CA9MEN1 | |
| SCHEMBL26037492 | 0.73 | CYP3A4 (0.43) | MEN1LMNAKMT2ATDP1ALDH1A1 | |
| Water SCHEMBL27536225 | 0.71 | CYP3A4 (0.41) | MEN1LMNAKMT2ATDP1ALDH1A1 | |
| Water SCHEMBL27787994 | 0.71 | TSHR (0.41) | CA1CA2CA7CA9LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9981243-B2 | Metal-organic frameworks | THE UNIVERSITY OF LIVERPOOL (GB) | 2018-05-29 | — | — | US | disclosed |
| US-20170333869-A1 | METAL-ORGANIC FRAMEWORKS | UNIV LIVERPOOL (GB) | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170333869-A1 | METAL-ORGANIC FRAMEWORKS | FOSB, MLX, AFF4 | CA1 1565/4885CA2 533/4885CA7 1332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.